Trial Profile

A Phase 1/2a Clinical Study to Evaluate the Efficacy of MEDI8852 in the Treatment of Influenza in Adults Challenged With a Wild-Type Influenza Strain

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 17 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MEDI 8852 (Primary) ; Oseltamivir
Indications Influenza A virus H1N1 subtype; Influenza A virus infections
Focus Adverse reactions; Pharmacodynamics
Sponsors MedImmune

Most Recent Events

16 Oct 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
02 Jul 2019 Planned End Date changed from 22 Oct 2019 to 9 Oct 2020.
02 Jul 2019 Planned primary completion date changed from 22 Oct 2019 to 9 Oct 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com